Cited by 67Nanoparticle-Based Drug DeliveryNanoplatforms for cancer theranosticsNanotechnology research and applications

Physical‐, chemical‐, and biological‐responsive nanomedicine for cancer therapy

Liao, Jinfeng, Jia, Yanpeng, Wu, Yongzhi, Shi, Kun, Yang, Dawei, Li, Pei, Qian, Zhiyong·2020·WIREs Nanomedicine and Nanobiotechnology

Abstract

Cancer therapy is unsatisfactory as it typically has serious side effects, because normal cells in healthy organs are destroyed along with the tumor. Thus, researchers have tried to develop effective therapies with minimal side effects. One such method is to use nanotechnology to carry the drugs or therapeutic agents to the tumor region by secure encapsulation without leakage. Once the nanomedicine enters the target tumor site, it can release therapeutic agents in an effective manner. Accordingly, various nanomedicines have been developed to enhance the efficiency of cancer therapy and minimize the systematic toxicity. Here, we provide an overview and discuss the different types of responsive nanomedicines including physically, chemically, biologically, dual, and multi‐responsive nanomedicines, for the in situ release of cargos in recent years. We propose critical considerations that must be considered for the design of excellent stimuli‐nanomedicine. Furthermore, the possible directions for the development of successful stimuli‐responsive (smart) nanomedicine are highlighted. With the development of responsive nanomedicines, precise and personalized nanomedicine will be realized with great promise in the future. This article is categorized under: Therapeutic Approaches and Drug Discovery > Nanomedicine for Oncologic Disease Nanotechnology Approaches to Biology > Nanoscale Systems in Biology

Integrity signals

Registry

Crossref · 10.1002/wnan.1581

Cites

175 of 175 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Some intracellular compartments are more acidic, like endosomes (pH ~5-6.5) and lysosomes (pH ~4.5-5).

    “However, some intracellular compartments are more acidic, like endosomes (pH ~5–6.5) and lysosomes (pH ~4.5–5).137”

    From Smart nanoparticles for cancer therapy (2023) · cites this paper as [137]

Cites

1 retracted

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Liao, J., Jia, Y., Wu, Y., Shi, K., Yang, D., Li, P., & Qian, Z.
Affiliations
  • Hong Kong Polytechnic University (HK)
  • Sichuan University (CN)
Corresponding author
Qian, Zhiyong
Venue
WIREs Nanomedicine and Nanobiotechnology
Publisher
Wiley
Published
2019-08-19
Volume
12
Issue
1
Pages
e1581-e1581
ISSN
  • 1939-0041 (ISSN-L)
  • 1939-5116
OpenAlex
W2969307565
Cited by
67
References
175
Citations by year
2026: 2 · 2025: 9 · 2024: 10 · 2023: 12 · 2022: 10 · 2021: 15 · 2020: 8 · 2019: 1
FWCI
0.54
Type
journal article
Language
en
Open access
closed
Locations
  • Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Natural Science Foundation of China (31525009, 31771096, 31600778)
  • National Key Research and Development of China (2017YFC1103500, 2017YFC1103502)
  • China Postdoctoral Science Foundation (0082204153001/003)
  • Sichuan University
Topics
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
  • Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
  • Physical Sciences › Engineering › Biomedical Engineering › Nanotechnology research and applications
Keywords
stimuli-responsive nanomedicine, cancer therapy, drug delivery, tumor-targeted drug release, in situ drug release, personalized medicine, nanomedicine design
MeSH terms
Theranostic Nanomedicine, Animals, Antineoplastic Agents, Humans, Neoplasms, Drug Delivery Systems, Nanomedicine, Mice, Drug Discovery

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review